Sandra Suarez‐Sharp

822 total citations
22 papers, 505 citations indexed

About

Sandra Suarez‐Sharp is a scholar working on Pharmaceutical Science, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Sandra Suarez‐Sharp has authored 22 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 10 papers in Materials Chemistry and 7 papers in Molecular Biology. Recurrent topics in Sandra Suarez‐Sharp's work include Drug Solubulity and Delivery Systems (13 papers), Crystallization and Solubility Studies (9 papers) and Protein purification and stability (7 papers). Sandra Suarez‐Sharp is often cited by papers focused on Drug Solubulity and Delivery Systems (13 papers), Crystallization and Solubility Studies (9 papers) and Protein purification and stability (7 papers). Sandra Suarez‐Sharp collaborates with scholars based in United States, United Kingdom and Sweden. Sandra Suarez‐Sharp's co-authors include Paul Seo, Tycho Heimbach, Filippos Kesisoglou, Xavier Pépin, Amitava Mitra, Andreas Abend, John Duan, Xinyuan Zhang, Min Li and Michael R. Cohen and has published in prestigious journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Sandra Suarez‐Sharp

22 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Suarez‐Sharp United States 11 337 167 139 97 71 22 505
Sivacharan Kollipara India 15 309 0.9× 126 0.8× 204 1.5× 103 1.1× 78 1.1× 46 643
Andreas Abend United States 17 225 0.7× 183 1.1× 358 2.6× 84 0.9× 64 0.9× 34 705
Henrike Potthast Germany 10 241 0.7× 97 0.6× 51 0.4× 110 1.1× 75 1.1× 20 421
Binfeng Xia United States 12 189 0.6× 50 0.3× 96 0.7× 66 0.7× 82 1.2× 19 470
Kimberly Raines United States 9 147 0.4× 69 0.4× 69 0.5× 44 0.5× 32 0.5× 13 256
Stefania Beato Switzerland 9 473 1.4× 224 1.3× 98 0.7× 97 1.0× 138 1.9× 10 640
Shriram M. Pathak India 11 219 0.6× 73 0.4× 78 0.6× 51 0.5× 66 0.9× 20 394
Jan Welink Netherlands 11 141 0.4× 29 0.2× 76 0.5× 72 0.7× 41 0.6× 25 459
Robert A. Lipper United States 5 143 0.4× 54 0.3× 74 0.5× 42 0.4× 62 0.9× 8 323
Sara Carlert Sweden 6 392 1.2× 159 1.0× 78 0.6× 86 0.9× 66 0.9× 12 512

Countries citing papers authored by Sandra Suarez‐Sharp

Since Specialization
Citations

This map shows the geographic impact of Sandra Suarez‐Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Suarez‐Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Suarez‐Sharp more than expected).

Fields of papers citing papers by Sandra Suarez‐Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Suarez‐Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Suarez‐Sharp. The network helps show where Sandra Suarez‐Sharp may publish in the future.

Co-authorship network of co-authors of Sandra Suarez‐Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Suarez‐Sharp. A scholar is included among the top collaborators of Sandra Suarez‐Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Suarez‐Sharp. Sandra Suarez‐Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mackie, Claire, Sumit Arora, Paul Seo, et al.. (2024). Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report. Molecular Pharmaceutics. 21(5). 2065–2080. 24 indexed citations
2.
Pépin, Xavier, et al.. (2024). Understanding the mechanisms of food effect on omaveloxolone pharmacokinetics through physiologically based biopharmaceutics modeling. CPT Pharmacometrics & Systems Pharmacology. 13(10). 1771–1783. 2 indexed citations
3.
Pépin, Xavier & Sandra Suarez‐Sharp. (2024). Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling. The AAPS Journal. 26(3). 54–54. 1 indexed citations
4.
Abend, Andreas, Przemysław Dorożyński, Nikoletta Fotaki, et al.. (2023). Report on the Virtual Workshop: A Quest for Biowaiver, Including Next Generation Dissolution Characterization and Modeling. Dissolution Technologies. 30(2). 100–108. 1 indexed citations
5.
LeBlond, David, et al.. (2022). DISSOLUTION PROFILE SIMILARITY ANALYSES—STATISTICAL PRINCIPLES, METHODS AND CONSIDERATIONS. The AAPS Journal. 24(3). 54–54. 9 indexed citations
6.
Heimbach, Tycho, Filippos Kesisoglou, Jasmina Novaković, et al.. (2021). Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies. Journal of Pharmaceutical Sciences. 110(12). 3896–3906. 41 indexed citations
7.
Bolger, Michael B., et al.. (2021). Predicting Pharmacokinetics of Multisource Acyclovir Oral Products Through Physiologically Based Biopharmaceutics Modeling. Journal of Pharmaceutical Sciences. 111(1). 262–273. 8 indexed citations
8.
Pépin, Xavier, Neil Parrott, Jennifer Dressman, et al.. (2020). Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report. Journal of Pharmaceutical Sciences. 110(2). 555–566. 41 indexed citations
9.
Suarez‐Sharp, Sandra, et al.. (2020). Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory Perspectives. Pharmaceutical Research. 37(6). 95–95. 9 indexed citations
10.
Pépin, Xavier, Jennifer Dressman, Neil Parrott, et al.. (2020). In Vitro Biopredictive Methods: A Workshop Summary Report. Journal of Pharmaceutical Sciences. 110(2). 567–583. 17 indexed citations
11.
Suarez‐Sharp, Sandra, et al.. (2020). In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, When—Workshop Summary Report. The AAPS Journal. 22(4). 74–74. 21 indexed citations
12.
Parrott, Neil, Sandra Suarez‐Sharp, Filippos Kesisoglou, et al.. (2020). Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report. Journal of Pharmaceutical Sciences. 110(2). 584–593. 19 indexed citations
13.
Heimbach, Tycho, Sandra Suarez‐Sharp, Nico Holmstock, et al.. (2019). Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report. The AAPS Journal. 21(2). 29–29. 78 indexed citations
14.
Abend, Andreas, Xujin Lu, Hanlin Li, et al.. (2019). Dissolution Testing in Drug Product Development: Workshop Summary Report. The AAPS Journal. 21(2). 21–21. 27 indexed citations
15.
Abend, Andreas, Tycho Heimbach, Michael R. Cohen, et al.. (2018). Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report. The AAPS Journal. 20(3). 60–60. 45 indexed citations
16.
Suarez‐Sharp, Sandra, Michael R. Cohen, Filippos Kesisoglou, et al.. (2018). Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report. The AAPS Journal. 20(6). 93–93. 61 indexed citations
17.
Suarez‐Sharp, Sandra, et al.. (2017). Application of an NLME–Stochastic Deconvolution Approach to Level A IVIVC Modeling. Journal of Pharmaceutical Sciences. 106(7). 1905–1916. 6 indexed citations
18.
Suarez‐Sharp, Sandra, Angelica Dorantes, John Duan, et al.. (2016). Regulatory Perspectives on Strength-Dependent Dissolution Profiles and Biowaiver Approaches for Immediate Release (IR) Oral Tablets in New Drug Applications. The AAPS Journal. 18(3). 578–588. 10 indexed citations
19.
Suarez‐Sharp, Sandra, et al.. (2016). Regulatory Experience with In Vivo In Vitro Correlations (IVIVC) in New Drug Applications. The AAPS Journal. 18(6). 1379–1390. 67 indexed citations
20.
Cruz, Celia N., Katherine M. Tyner, Kenneth C. Hyams, et al.. (2013). CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products. The AAPS Journal. 15(3). 623–628. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sivacharan Kollipara Breakdown of academic impact, for papers by Andreas Abend Breakdown of academic impact, for papers by Henrike Potthast Breakdown of academic impact, for papers by Binfeng Xia Breakdown of academic impact, for papers by Kimberly Raines Breakdown of academic impact, for papers by Stefania Beato Breakdown of academic impact, for papers by Shriram M. Pathak Breakdown of academic impact, for papers by Jan Welink Breakdown of academic impact, for papers by Robert A. Lipper Breakdown of academic impact, for papers by Sara Carlert
Rankless by CCL
2026